EUVIMEDEUVIMED entdecken
Multizentrische Studie

Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study

Tobias Warnecke, Per Odin, Rocío García-Ramos, Lydia Lopez, Delia Tulbă, Traian Flavius Dan, Dragos Catalin Jianu, Petra Bago Rožanković, Teus van Laar

Journal of Neural Transmission · 2026-04 · 133 (4) · 779-789

DOI: 10.1007/s00702-025-03033-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neural Transmission, online erschienen am 06.10.2025. Verfasst von Tobias Warnecke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurorehabilitation, Klinikum Osnabrück, Academic Teaching Hospital of the University of Münster, Am Finkenhügel 1, Osnab…. Hauptthemen laut MEDLINE: Carbidopa, Levodopa, Parkinson Disease, Antiparkinson Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Britannia Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbidopaLevodopaParkinson DiseaseAntiparkinson AgentsCatecholsNitrilesHumansMaleFemaleDrug CombinationsAgedMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

Advanced Parkinson’s diseaseClinical practiceLevodopa–entacapone–carbidopa intestinal gelNon-Motor Symptoms ScaleNon-motor symptoms

Substanzen

CarbidopaLevodopaDrug CombinationsAntiparkinson Agentscarbidopa, levodopa drug combinationCatecholsNitrilesentacapone

Autor:innen und Institutionen

  • Department of Neurology and Neurorehabilitation, Klinikum Osnabrück, Academic Teaching Hospital of the University of Münster, Am Finkenhügel 1, Osnabrück, Germany. tobias.warnecke@klinikum-os.de.
  • Division of Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
  • Movement Disorders Unit, San Carlos Clinical Hospital, Complutense University of Madrid, Madrid, Spain.
  • Department of Neurology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Department of Clinical Neurosciences, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Förderung

  • Britannia Pharmaceuticals

Zitieren

APA

Warnecke, T., Odin, P., García-Ramos, R., Lopez, L., Tulbă, D., Dan, T. F., Jianu, D. C., Rožanković, P. B., & van Laar, T. (2026). Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study. Journal of Neural Transmission, 133(4), 779-789. https://doi.org/10.1007/s00702-025-03033-8

Vancouver

Warnecke T, Odin P, García-Ramos R, Lopez L, Tulbă D, Dan TF, et al. Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study. Journal of Neural Transmission. 2026;133(4):779-789. doi:10.1007/s00702-025-03033-8

BibTeX
@article{Warnecke2026,
  author = {Warnecke, Tobias and Odin, Per and García-Ramos, Rocío and Lopez, Lydia and Tulbă, Delia and Dan, Traian Flavius and Jianu, Dragos Catalin and Rožanković, Petra Bago and van Laar, Teus},
  title = {Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study},
  journal = {Journal of Neural Transmission},
  year = {2026},
  volume = {133},
  number = {4},
  pages = {779--789},
  doi = {10.1007/s00702-025-03033-8}
}
Kostenlos starten →